FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

NIGON RICHARD 		2. Issuer Name and Ticker or Trading Symbol

VASCULAR SOLUTIONS INC [ VASC ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O VASCULAR SOLUTIONS, INC., 6464 SYCAMORE COURT NORTH 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/17/2017
(Street)

MINNEAPOLIS, MN 55369
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  61228   D    
Common Stock   2/17/2017     D    61228   D   (1) 0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $9.41   2/17/2017     D         10000      (2) 4/24/2017   Common Stock   10000   $46.59   0   D    
Stock Option (Right to Buy)   $6.36   2/17/2017     D         10000      (3) 4/22/2018   Common Stock   10000   $49.64   0   D    
Stock Option (Right to Buy)   $6.39   2/17/2017     D         10000      (4) 4/21/2019   Common Stock   10000   $49.61   0   D    
Stock Option (Right to Buy)   $9.61   2/17/2017     D         10000      (5) 4/22/2020   Common Stock   10000   $46.39   0   D    
Stock Option (Right to Buy)   $11.72   2/17/2017     D         10000      (6) 4/22/2021   Common Stock   10000   $44.28   0   D    
Stock Option (Right to Buy)   $11.63   2/17/2017     D         10000      (7) 5/4/2022   Common Stock   10000   $44.37   0   D    

Explanation of Responses:
( 1)  In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.
( 2)  This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $465,900, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
( 3)  This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $496,400, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
( 4)  This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $496,100, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
( 5)  This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $463,900, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
( 6)  This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $442,800, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
( 7)  This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $443,700, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
NIGON RICHARD
C/O VASCULAR SOLUTIONS, INC.
6464 SYCAMORE COURT NORTH
MINNEAPOLIS, MN 55369 		X



Signatures
/s/ Richard Nigon 2/22/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Vascular Solutions, Inc. (NASDAQ:VASC)
Historical Stock Chart
Von Okt 2024 bis Nov 2024 Click Here for more Vascular Solutions, Inc. Charts.
Vascular Solutions, Inc. (NASDAQ:VASC)
Historical Stock Chart
Von Nov 2023 bis Nov 2024 Click Here for more Vascular Solutions, Inc. Charts.